Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.970
-0.040 (-3.92%)
Dec 3, 2024, 12:24 PM EST - Market open
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $59.91 million as of December 3, 2024. Its market cap has increased by 74.17% in one year.
Market Cap
59.91M
Enterprise Value
3.38M
1-Year Change
74.17%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $59.91M, a decrease of -93.74%. That is a compound annual growth rate of -44.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 29, 2024 | 69.80M | 26.06% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicycive Therapeutics | 71.51M |
| 111, Inc. | 71.09M |
| Atara Biotherapeutics | 70.12M |
| Exagen | 70.02M |
| Cryo-Cell International | 69.88M |
| Monogram Technologies | 69.31M |
| Modular Medical | 68.24M |
| DBV Technologies | 68.22M |